Author:
Vargas Valencia Juan Jesús,Alva Esqueda Mónica Elena
Reference22 articles.
1. Use of bevacizumab in metastatic colorectal cancer report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009);Zinser;Drugs R D 2,2011
2. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013
3. Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after firstline chemotherapy. NICE technology appraisal guidance 242. January 2012. [Consultado 1 de septiembre 2014]. Disponible en: www.nice.org.uk/ta242
4. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). 2014. [Consultado 7 de septiembre 2014]. Disponible en: http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Registro necesario.
5. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making;Schmoll;Ann Oncol,2012
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献